Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q3 2025 Earnings Call Transcript

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q3 2025 Earnings Call Transcript November 12, 2025

Acumen Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.43668, expectations were $-0.63.

Operator: Good day, and welcome to the Acumen Pharma Third Quarter 2025 Conference Call and Webcast. [Operator Instructions] As a reminder, this call may be recorded. I would now like to turn the call over to Alex Braun, Head of Investor Relations. Please go ahead.

Alex Braun: Thanks,...